Method of treating/managing Cancer is disclosed in various embodiments herein. The disclosed method includes the use of a combination of formulations and therapies that provide a holistic approach in treating or managing cancer. The method further includes practices of Ayurveda that facilitate in holistic healing of cancer patients.

Method of treating/managing Cancer is disclosed in various embodiments herein. The disclosed method includes the use of a combination of formulations and therapies that provide a holistic approach in treating or managing cancer. The method further includes practices of Ayurveda that facilitate in holistic healing of cancer patients.

The present disclosure relates to a herbo-mineral metallic pharmaceutical kit for delaying/controlling recurrence and/or metastasis of cancer in Triple Negative Breast Cancer (TNBC) patients. The herbo-mineral metallic pharmaceutical kit comprises a first container containing Suvarna Bhasmadi Vati (SBV), a second container containing Mouktikyukta Kamdudha Vati (MKV), a third container containing Shatavari Vati (SV), a fourth container containing Arogyavardhini Vati (AVV), a fifth container containing Triphala Guggul Vati (TGV) and a sixth container containing jatamansi Oil (JMO). The herbo mineral metallic pharmaceutical kit assists in improving immunomodulatory response and reducing oxidative stress in TNBC patients.

The present disclosure relates to a herbo-mineral metallic pharmaceutical kit for delaying/controlling recurrence and/or metastasis of cancer in Triple Negative Breast Cancer (TNBC) patients. The herbo-mineral metallic pharmaceutical kit comprises a first container containing Suvarna Bhasmadi Vati (SBV), a second container containing Mouktikyukta Kamdudha Vati (MKV), a third container containing Shatavari Vati (SV), a fourth container containing Arogyavardhini Vati (AVV), a fifth container containing Triphala Guggul Vati (TGV) and a sixth container containing jatamansi Oil (JMO). The herbo mineral metallic pharmaceutical kit assists in improving immunomodulatory response and reducing oxidative stress in TNBC patients.

The present invention relates to the preparation technical field of traditional Chinese medicine and more particularly, to a traditional Chinese medicine eye drops and the preparation method thereof. The traditional Chinese medicine components of the traditional Chinese medicine eye drops provided by the embodiments of the invention comprise: ginseng Radix et rhizoma of 5-10 wt %, scrophulariae Radix of 15-20 wt %, xanthii Fructus of 5-10 wt %, bovis Calculus sativus of 5-10 wt %, Carthami flos of 5-10 wt %, borneolum of 5-10 wt %, senecionis scandentis herba of 25-35 wt %, fibraureae caulis of 5-15 wt % and motherwort fruit of 5-10 wt %.

The present invention relates to the preparation technical field of traditional Chinese medicine and more particularly, to a traditional Chinese medicine eye drops and the preparation method thereof. The traditional Chinese medicine components of the traditional Chinese medicine eye drops provided by the embodiments of the invention comprise: ginseng Radix et rhizoma of 5-10 wt %, scrophulariae Radix of 15-20 wt %, xanthii Fructus of 5-10 wt %, bovis Calculus sativus of 5-10 wt %, Carthami flos of 5-10 wt %, borneolum of 5-10 wt %, senecionis scandentis herba of 25-35 wt %, fibraureae caulis of 5-15 wt % and motherwort fruit of 5-10 wt %.

A method and a composition for improving gut micro biota structure, selectively increase a first gut microbiota population while simultaneously decrease a second gut micro biota population in a subject. The first gut micro biota population includes a short-chain fatty acid (SCFA)-producing bacterium and the second gut microbiota population includes an endotoxin-producing bacterium.

A method and a composition for improving gut micro biota structure, selectively increase a first gut microbiota population while simultaneously decrease a second gut micro biota population in a subject. The first gut micro biota population includes a short-chain fatty acid (SCFA)-producing bacterium and the second gut microbiota population includes an endotoxin-producing bacterium.

A method and a composition for improving gut micro biota structure, selectively increase a first gut microbiota population while simultaneously decrease a second gut micro biota population in a subject. The first gut micro biota population includes a short-chain fatty acid (SCFA)-producing bacterium and the second gut microbiota population includes an endotoxin-producing bacterium.

Herbo-mineral formulation for prevention and treatment of Renal disorders are disclosed herein. The formulation includes combination of herb and mineral elements for treating Renal disorders. Renal disorders include any condition associated with Kidney function such as Chronic renal failure.